the considerations inherent in the preclinical evaluation of factors acting primarily on hematopoietic cells , erythropoietin ( epo ) , interleukins ( il 's ) and colony stimulating factors ( csf ) ( 1 ) will be discussed using case examples .
C0014822
erythropoietin
C0009392
colony stimulating factors